VistaGen Therapeutics Inc (VTGN)

2.16 -0.03  -1.37% NASDAQ Apr 9, 20:00 USD
View Full Chart
Price Chart
View All VTGN News


View All Events


Date Type Description
06/29/2020 00:00 Earnings Results Q4 2020 Earnings Results
08/13/2020 00:00 Earnings Results Q1 2021 Earnings Results
09/17/2020 10:00 PDT Agm 2020 Annual General Meeting
11/12/2020 00:00 Earnings Results Q2 2021 Earnings Results
02/11/2021 00:00 Earnings Results Q3 2021 Earnings Results
06/29/2021 00:00 Earnings Results Q4 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL:
  • Investor Relations URL: N/A
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Jun. 29, 2021
  • Last Earnings Release: Feb. 11, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants. The PH94B is a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia; PH10 is an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression.





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.